Alterity Therapeutics (PRNAD) Net Income - Minority (2009 - 2019)

Alterity Therapeutics (PRNAD) has reported Net Income - Minority for 9 consecutive years, with -$109.7 million the latest figure, recorded in Q2 2019.

• In Q2 2019, Net Income - Minority fell 0.71% year-over-year to -$109.7 million; the TTM figure through Jun 2019 stood at -$109.7 million (down 0.71% YoY), while the FY2019 annual figure was -$112.1 million, down 2.88% from the prior year.
• Net Income - Minority came in at -$109.7 million for Q2 2019 at Alterity Therapeutics, down from -$108.9 million in the prior quarter.
• The five-year high for Net Income - Minority was -$108.2 million in Q2 2017, with the low at -$109.7 million in Q2 2019.
• Average Net Income - Minority over 4 years is -$109.1 million, with a median of -$109.3 million recorded in 2016.
• Across the five-year window, Net Income - Minority grew 1.36% in 2017 and declined 0.71% in 2019, its largest moves.
• Year by year, Net Income - Minority stood at -$109.7 million in 2016, then rose by 1.36% to -$108.2 million in 2017, then retreated by 0.7% to -$108.9 million in 2018, then slipped by 0.71% to -$109.7 million in 2019.
• According to Business Quant data, Net Income - Minority over the past three periods registered -$109.7 million, -$108.9 million, and -$108.2 million for Q2 2019, Q2 2018, and Q2 2017 respectively.